14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
UCL vs ATEX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Anterix Inc. (ATEX) captures the overall head-to-head institutional edge over uCloudlink Group Inc. (UCL) on higher Unified Composite conviction (41.2/100 SELL vs. 50.0/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Profitability & Quality), while UCL wins 3–2 across the 6-pillar growth and valuation breakdown. UCL trades at $0.21 (14.4x Forward P/E, -16.6% operating margin) versus ATEX at $67.37 (N/M Forward P/E, -573.6% operating margin).
Composite vs. Pillar Nuance: While UCL currently prints a higher short-term Unified Composite Score (50.0/100 HOLD vs. ATEX 41.2/100 SELL), ATEX captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (-573.6% vs. -16.6% operating margin) and revenue trajectory (+26.2% vs. +1.1% YoY).
Technical & Structure Timing Caution: UCL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.5); meanwhile ATEX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UCL vs ATEX. Trailing 12-month operating profitability (UCL -16.6% vs ATEX -573.6%) and valuation multiples (UCL 14.4x vs ATEX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Telecom Services value chain with $1.5B market capitalization and -573.6% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ UCL vs ATEX Key Questions & Quantitative Answers
As of Nov 20, 2026, Anterix Inc. (ATEX) captures the overall head-to-head institutional edge over uCloudlink Group Inc. (UCL) on higher Unified Composite conviction (41.2/100 SELL vs. 50.0/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Profitability & Quality), while UCL wins 3–2 across the 6-pillar growth and valuation breakdown. UCL trades at $0.21 (14.4x Forward P/E, -16.6% operating margin) versus ATEX at $67.37 (N/M Forward P/E, -573.6% operating margin). Composite vs. Pillar Nuance: While UCL currently prints a higher short-term Unified Composite Score (50.0/100 HOLD vs. ATEX 41.2/100 SELL), ATEX captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (-573.6% vs. -16.6% operating margin) and revenue trajectory (+26.2% vs. +1.1% YoY). Technical & Structure Timing Caution: UCL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.5); meanwhile ATEX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ATEX leads the Growth & Scale pillar: UCL posts +1.1% YoY revenue growth and +122.4% YoY earnings growth on $79M TTM revenue (50.8% gross margin, -16.6% operating margin), compared with ATEX at +26.2% YoY revenue growth and -99.3% YoY earnings growth on $7.4M TTM revenue (100.0% gross margin, -573.6% operating margin). On trailing 12-month operating scale, UCL generates $79M in USD-normalized revenue versus $7.4M for ATEX. In operating R&D and SG&A reinvestment, UCL deploys 67.4% of Rev ($53M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ATEX.
UCL screens cheaper on headline valuation multiples. UCL trades at 14.4x Forward P/E, 14.4x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-12.1% EBITDA margin), whereas ATEX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UCL (-36.3% ROE) versus ATEX (2.7% ROE) capital efficiency.
In options market volatility and institutional positioning, UCL carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.73β · 129% Vol realized risk). By comparison, ATEX carries 84.8% implied volatility (17th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.15β · 97% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.